Results 281 to 290 of about 404,117 (334)
ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
ESC Heart Failure, EarlyView.Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit +3 more
wiley +1 more source
After the Madness: A Continued Journey Through Fiction Writing [PDF]
, 2016 Drake, Hannah Landau
core +1 more source
ESC Heart Failure, EarlyView.Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner +10 more
wiley +1 more source
Recurrent Diffuse Neurofibroma of the Mandibular Anterior Lingual Alveolar Process Associated With Dental and Skeletal Changes in Neurofibromatosis Type 1. [PDF]
Cancer Diagn PrognFriedrich RE, Kohlrusch FK, Hagel C.
europepmc +1 more source
ESC Heart Failure, EarlyView.Routine data analysis showing a better outcome regarding mortality and readmission in HF patients when being prescribed the current four‐drug treatment (vs. the outdated two‐drug therapy) 91–365 days after index hospital stay. Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy ...
Martin Möckel +9 more
wiley +1 more source
Comparative analysis of oral microbiome in saliva samples of oral leukoplakia, proliferative leukoplakia and oral squamous cell carcinoma. [PDF]
Front Oral HealthIntini R +5 more
europepmc +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
ESC Heart Failure, EarlyView.Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna +4 more
wiley +1 more source